TrialPath
Recruiting

Total en Bloc Urethra Preservation at Robot-assisted Prostatectomy IDEAL Stage 2a

NCT07678489 · Jung Stilling Hospital
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Total en Bloc Urethra Preservation at Robot-assisted Prostatectomy (ToP-RAP): A Prospective IDEAL Stage 2a Study
About this study
Our study introduces a urethra-preserving prostatectomy concept that maintains the entire intraprostatic urethra, thereby avoiding both urethral transection and vesicourethral anastomosis. We embed the technique in a transparent IDEAL-based framework with predefined intra-operative decision rules, including prespecified conversion to standard robot-assisted radical prostatectomy. This positions the technique as a distinct step beyond existing bladder neck- or urethra-sparing modifications, and provides the first prospective multicentre data supporting its feasibility in selected patients.
Eligibility criteria
Inclusion criteria: * Life expectancy \>=10 years (biological age) * No prior prostate therapy (laser enucleation, TURP, focal therapy) * No pelvic/prostate radiotherapy; * No prior abdominal/rectal surgery; * No prior (neoadjuvant) androgen-deprivation therapy * No prior stroke/cerebral ischemia with neurological sequelae; * No neurological disease (e.g., Parkinson's) * Transrectal or transperineal bilateral biopsy \>=12 cores (MRI-ultrasound fusion, targeted + systematic) * PSA \<=15 ng/mL; prostate volume \<=80 mL * Biopsy ISUP grade 1-3 (= Gleason 3+3 / 3+4 / 4+3) * No Gleason pattern 5; no intraductal, cribriform or neuroendocrine carcinoma * mp/bpMRI (mandatory if biopsy Gleason \>=3+4) * No suspected metastases at staging Exclusion Criteria: \- Failure to meet any inclusion criterion, or patient declining ToP-RAP (offered standard RARP per EAU guidelines)
Study design
Enrollment target: 60 participants
Allocation: na
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2024-01-30
Estimated completion: 2030-12-31
Last updated: 2026-07-01
Interventions
Procedure: ToP-RAP
Primary outcomes
  • • Technical feasibility of ToP-RAP (Intraoperative (day of surgery))
  • • Perioperative safety (Clavien-Dindo) (Up to 90 days after surgery)
  • • Time to urinary continence recovery (Up to 12 months after surgery)
Sponsor
Sami-Ramzi Leyh-Bannurah · other
With: Clinic Bel Etage Dusseldorf, NRW, Germany
Contacts & investigators
InvestigatorSami-Ramzi Leyh-Bannurah, Associate Professor · study_director, Martini Klinik am UKE GmbH, Hamburg-Eppendorf, Hamburg, Germany
All locations (2)
Clinic Bel EtageRecruiting
Düsseldorf, Germany
Diakonie Klinikum Jung-StillingRecruiting
Siegen, Germany